Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1932: Targeted Drugs, PADN, and Transcatheter Closure for Atrial Septal Defect-associated Pulmonary Hypertension: Case Series

Presenter: Nanchao Hong

October 26, 2025

News Conference News TCT 2022

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Shelley Wood

September 18, 2022

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

News Conference News TCT 2018

Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure

Todd Neale

September 23, 2018

Presentation TCT 2018

PADN-5: A Randomized Trial of Pulmonary Artery Denervation in Patients With Combined Pre- and Postcapillary Pulmonary Hypertension

Presenter: Valentin Fuster, Shao-Liang Chen

September 23, 2018

Presentation TCT 2017

Pulmonary Artery Denervation With a Radiofrequency Catheter: PADN Study Results

Presenter: Irene M. Lang, Ehtisham Mahmud, Hang Zhang

November 01, 2017

News Conference News TCT 2013

Pulmonary Artery Denervation Procedure May Improve Hemodynamic Outcomes in PAH

November 05, 2013

Presentation TCT 2013

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Presenter: Shao-?Liang Chen

October 29, 2013

Presentation TCT 2013

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

Presenter: Shao Liang Chen

October 28, 2013

News Conference News TCT 2012

Pulmonary Artery Denervation Effective for PAH

October 24, 2012

$PADN-1: Pulmonary Artery Denervation for the Treatment of Refractory Pulmonary Hypertension$

Presentation TCT 2012

PADN-1: Pulmonary Artery Denervation for the Treatment of Refractory Pulmonary Hypertension

Presenter: Shao Liang Chen

October 22, 2012

Advertisement

TCT 1932: Targeted Drugs, PADN, and Transcatheter Closure for Atrial Septal Defect-associated Pulmonary Hypertension: Case Series

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure

PADN-5: A Randomized Trial of Pulmonary Artery Denervation in Patients With Combined Pre- and Postcapillary Pulmonary Hypertension

Pulmonary Artery Denervation With a Radiofrequency Catheter: PADN Study Results

Pulmonary Artery Denervation Procedure May Improve Hemodynamic Outcomes in PAH

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Pulmonary Artery Denervation for Pulmonary Hypertension: PADN-1 Results and Fuure Clinical Studies

Pulmonary Artery Denervation Effective for PAH

PADN-1: Pulmonary Artery Denervation for the Treatment of Refractory Pulmonary Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content